You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康恩貝(600572.SH):與康臣藥業集團簽訂戰略合作框架協議
格隆匯 01-07 16:25

格隆匯1月7日丨康恩貝(600572.SH)公佈,2022年1月7日,公司和康臣藥業集團有限公司(康臣藥業集團)在杭州市濱江區濱康路568號康恩貝中心簽訂了《浙江康恩貝製藥股份有限公司與康臣藥業集團有限公司之戰略合作框架協議》。

基於對促進中醫藥傳承創新發展使命的共識和需要,康恩貝和康臣藥業集團經過友好協商,決定充分發揮雙方的優勢,以產業和資本合作為紐帶,通過強強聯合、優勢互補、業務與資產整合,推進甲乙雙方在醫藥大健康產業尤其是中醫藥健康產業領域的戰略合作,加快康恩貝打造浙江省中醫藥健康產業主平台和中國中醫藥健康產業的龍頭企業之一的進程,同時也助力康臣藥業集團成為中國泌尿系統特別是腎病中藥健康領域的龍頭企業。雙方本着平等互利的原則,簽訂該框架協議。

本次公司與康臣藥業集團簽署《合作框架協議》,有利於建立和推進雙方的戰略合作關係,有效協同與整合雙方資源,進一步發揮公司多方面的綜合優勢,促進公司中藥大健康核心業務的持續發展,提升核心競爭力,符合公司戰略發展需要。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account